{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:02Z","timestamp":1792819142958,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Outstanding Youth Fund Project of Hunan Province","award":["2024JJ2090"],"award-info":[{"award-number":["2024JJ2090"]}]},{"name":"Outstanding Youth Fund Project of Hunan Province","award":["2024JJ2094"],"award-info":[{"award-number":["2024JJ2094"]}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2023LNJJ13"],"award-info":[{"award-number":["2023LNJJ13"]}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2023LNJJ16"],"award-info":[{"award-number":["2023LNJJ16"]}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2020LNJJ01"],"award-info":[{"award-number":["2020LNJJ01"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272907"],"award-info":[{"award-number":["82272907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974397"],"award-info":[{"award-number":["81974397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572524"],"award-info":[{"award-number":["81572524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91859207"],"award-info":[{"award-number":["91859207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771873"],"award-info":[{"award-number":["81771873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272045"],"award-info":[{"award-number":["82272045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273121"],"award-info":[{"award-number":["82273121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91859207"],"award-info":[{"award-number":["91859207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801740"],"award-info":[{"award-number":["81801740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Hunan Province","award":["2023SK2017"],"award-info":[{"award-number":["2023SK2017"]}]},{"name":"Key Program of Ministry of Industry and Information Technology of China","award":["CEIEC-2022-ZM02-0219"],"award-info":[{"award-number":["CEIEC-2022-ZM02-0219"]}]},{"name":"Science and Technology Innovation Program of Hunan Province","award":["2021RC4056"],"award-info":[{"award-number":["2021RC4056"]}]},{"name":"National Key Research and Development Plan","award":["2017YFC0908004"],"award-info":[{"award-number":["2017YFC0908004"]}]},{"name":"Clinical Big Data System Construction Project Fund of Xiangya Hospital","award":["33020125030"],"award-info":[{"award-number":["33020125030"]}]},{"name":"Xiangya Famous Doctor Fund of Central South University","award":["33020123007"],"award-info":[{"award-number":["33020123007"]}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2023ZZTS0551"],"award-info":[{"award-number":["2023ZZTS0551"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2024ZZTS0870"],"award-info":[{"award-number":["2024ZZTS0870"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M23561"],"award-info":[{"award-number":["2022M23561"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00259-025-07140-2","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T05:41:09Z","timestamp":1740202869000},"page":"2826-2840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET\/CT imaging"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-3268","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-2452","authenticated-orcid":false,"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3987-8702","authenticated-orcid":false,"given":"Yongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-5825","authenticated-orcid":false,"given":"Xiaomei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-8943","authenticated-orcid":false,"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-2064","authenticated-orcid":false,"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"issue":"3","key":"7140_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7140_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","volume":"21","author":"KA Moses","year":"2023","unstructured":"Moses KA, Sprenkle PC, Bahler C, et al. NCCN Guidelines\u00ae Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023;21(3):236\u201346.","journal-title":"J Natl Compr Canc Netw."},{"issue":"2","key":"7140_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update.Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol."},{"issue":"5","key":"7140_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","volume":"3","author":"UG Falagario","year":"2020","unstructured":"Falagario UG, Martini A, Wajswol E, et al. Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators. Eur Urol Oncol. 2020;3(5):700\u20134.","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"7140_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1148\/radiol.2021202771","volume":"299","author":"C Lawhn-Heath","year":"2021","unstructured":"Lawhn-Heath C, Salavati A, Behr SC, et al. Prostate-specific Membrane Antigen PET in Prostate Cancer. Radiology. 2021;299(2):248\u201360.","journal-title":"Radiology"},{"issue":"5","key":"7140_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.120.257238","volume":"62","author":"A Farolfi","year":"2021","unstructured":"Farolfi A, Calderoni L, Mattana F, et al. Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. J Nucl Med. 2021;62(5):596\u2013604.","journal-title":"J Nucl Med"},{"issue":"8","key":"7140_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41585-022-00618-w","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Galante JR, Haroon A, et al. The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer. Nat Rev Urol. 2022;19(8):475\u201393.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"7140_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/JU.0000000000003680","volume":"210","author":"W Tang","year":"2023","unstructured":"Tang W, Tang Y, Qi L, et al. Benign prostatic hyperplasia-related false-positive of prostate-specific membrane antigen-positron emission tomography in the diagnosis of prostate cancer: the achilles\u2019 heel of biopsy-free radical prostatectomy? J Urol. 2023;210(6):845\u201355.","journal-title":"J Urol"},{"issue":"4","key":"7140_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2019.06.030","volume":"76","author":"A Paschalis","year":"2019","unstructured":"Paschalis A, Sheehan B, Riisnaes R, et al. Prostate-specific membrane antigen heterogeneity and dna repair defects in prostate cancer. Eur Urol. 2019;76(4):469\u201378.","journal-title":"Eur Urol"},{"issue":"7","key":"7140_CR10","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00259-023-06142-2","volume":"50","author":"X Gao","year":"2023","unstructured":"Gao X, Tang Y, Chen M, et al. A prospective comparative study of [(68)Ga]Ga-RM26 and [(68)Ga]Ga-PSMA-617 PET\/CT imaging in suspicious prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(7):2177\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"7140_CR11","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1097\/RLU.0000000000005064","volume":"49","author":"N Erg\u00fcl","year":"2024","unstructured":"Erg\u00fcl N, \u00c7ermik TF, Al\u00e7\u0131n G, et al. Contribution of 68 Ga-DOTA-FAPI-04 PET\/CT to Prostate Cancer Imaging\u202f: Complementary Role in PSMA-Negative Cases. Clin Nucl Med. 2024;49(3):e105\u201310.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"7140_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (primary): a prospective multicentre study. Eur Urol. 2021;80(6):682\u20139.","journal-title":"Eur Urol"},{"issue":"1","key":"7140_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40644-023-00599-y","volume":"23","author":"W Yu","year":"2023","unstructured":"Yu W, Zhao M, Deng Y, et al. Meta-analysis of (18) F-PSMA-1007 PET\/CT, (18) F-FDG PET\/CT, and (68)Ga-PSMA PET\/CT in diagnostic efficacy of prostate Cancer. Cancer Imaging. 2023;23(1):77.","journal-title":"Cancer Imaging"},{"issue":"8","key":"7140_CR14","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s00259-021-05636-1","volume":"49","author":"DX Qiu","year":"2022","unstructured":"Qiu DX, Li J, Zhang JW, et al. Dual-tracer PET\/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2022;49(8):2821\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7140_CR15","first-page":"885","volume":"47","author":"D Delbeke","year":"2006","unstructured":"Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0. J Nucl Med. 2006;47(5):885\u201395.","journal-title":"J Nucl Med."},{"issue":"2","key":"7140_CR16","doi-asserted-by":"publisher","first-page":"188641","DOI":"10.1016\/j.bbcan.2021.188641","volume":"1876","author":"FM Barnieh","year":"2021","unstructured":"Barnieh FM, Loadman PM, Falconer RA. Is tumour-expressed aminopeptidase N (APN\/CD13) structurally and functionally unique? Biochim Biophys Acta Rev Cancer. 2021;1876(2):188641.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"7140_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"P Mina-Osorio","year":"2008","unstructured":"Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med. 2008;14(8):361\u201371.","journal-title":"Trends Mol Med"},{"issue":"6","key":"7140_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/092986707780059571","volume":"14","author":"Y Luan","year":"2007","unstructured":"Luan Y, Xu W. The structure and main functions of aminopeptidase N. Curr Med Chem. 2007;14(6):639\u201347.","journal-title":"Curr Med Chem"},{"key":"7140_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2407-7-140","volume":"7","author":"M Terauchi","year":"2007","unstructured":"Terauchi M, Kajiyama H, Shibata K, et al. Inhibition of APN\/CD13 leads to suppressed progressive potential in ovarian carcinoma cells. BMC Cancer. 2007;7:140.","journal-title":"BMC Cancer"},{"issue":"3","key":"7140_CR20","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3892\/or.2014.3693","volume":"33","author":"S Liu","year":"2015","unstructured":"Liu S, Xie F, Wang H, et al. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated. Oncol Rep. 2015;33(3):1372\u201380.","journal-title":"Oncol Rep"},{"issue":"4","key":"7140_CR21","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3892\/or.2016.4611","volume":"35","author":"X Wang","year":"2016","unstructured":"Wang X, Niu Z, Jia Y, et al. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells. Oncol Rep. 2016;35(4):2121\u201330.","journal-title":"Oncol Rep"},{"issue":"5","key":"7140_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1073\/pnas.1120790109","volume":"109","author":"L Guzman-Rojas","year":"2012","unstructured":"Guzman-Rojas L, Rangel R, Salameh A, et al. Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment. Proc Natl Acad Sci U S A. 2012;109(5):1637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"7140_CR23","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1021\/acssensors.3c00730","volume":"8","author":"YJ Yang","year":"2023","unstructured":"Yang YJ, Dai M, Ahn KH. Cell-Membrane-Localizing Fluorescence Probes for Aminopeptidase N. ACS Sens. 2023;8(7):2791\u20138.","journal-title":"ACS Sens"},{"issue":"15","key":"7140_CR24","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1021\/acs.jmedchem.7b00782","volume":"61","author":"SA Amin","year":"2018","unstructured":"Amin SA, Adhikari N, Jha T. Design of aminopeptidase n inhibitors as anti-cancer agents. J Med Chem. 2018;61(15):6468\u201390.","journal-title":"J Med Chem"},{"issue":"1","key":"7140_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-020-00865-7","volume":"13","author":"JM Dom\u00ednguez","year":"2020","unstructured":"Dom\u00ednguez JM, P\u00e9rez-Chac\u00f3n G, Guill\u00e9n MJ, et al. CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110. J Hematol Oncol. 2020;13(1):32.","journal-title":"J Hematol Oncol"},{"issue":"24 Pt 1","key":"7140_CR26","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1158\/1078-0432.CCR-05-1005","volume":"11","author":"H Murakami","year":"2005","unstructured":"Murakami H, Yokoyama A, Kondo K, Nakanishi S, Kohno N, Miyake M. Circulating aminopeptidase N\/CD13 is an independent prognostic factor in patients with non-small cell lung cancer. Clin Cancer Res. 2005;11(24 Pt 1):8674\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5349","key":"7140_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.279.5349.377","volume":"279","author":"W Arap","year":"1998","unstructured":"Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 1998;279(5349):377\u201380.","journal-title":"Science"},{"issue":"1","key":"7140_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00259-023-06412-z","volume":"51","author":"X Lv","year":"2023","unstructured":"Lv X, Song X, Long Y, Zeng D, Lan X, Gai Y. Preclinical evaluation of a dual-receptor targeted tracer [(68)Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models. Eur J Nucl Med Mol Imaging. 2023;51(1):54\u201367.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7140_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1021\/acs.molpharmaceut.9b01134","volume":"17","author":"Y Gai","year":"2020","unstructured":"Gai Y, Jiang Y, Long Y, et al. Evaluation of an Integrin \u03b1(v)\u03b2(3) and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging. Mol Pharm. 2020;17(1):349\u201358.","journal-title":"Mol Pharm"},{"key":"7140_CR30","doi-asserted-by":"publisher","first-page":"119881","DOI":"10.1016\/j.ijpharm.2020.119881","volume":"589","author":"A Kis","year":"2020","unstructured":"Kis A, D\u00e9nes N, Szab\u00f3 JP, et al. In vivo assessment of aminopeptidase N (APN\/CD13) specificity of different (68)Ga-labelled NGR derivatives using PET\/MRI imaging. Int J Pharm. 2020;589:119881.","journal-title":"Int J Pharm"},{"issue":"1","key":"7140_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7150\/jca.49628","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhang J, Zou H, Shen Y, Deng S, Wu Y. Synthesis and evaluation of (68)Ga-labeled dimeric cNGR peptide for PET imaging of CD13 expression with ovarian cancer xenograft. J Cancer. 2021;12(1):244\u201352.","journal-title":"J Cancer"},{"issue":"20","key":"7140_CR32","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2008-04-150318","volume":"113","author":"R Bieker","year":"2009","unstructured":"Bieker R, Kessler T, Schw\u00f6ppe C, et al. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood. 2009;113(20):5019\u201327.","journal-title":"Blood"},{"issue":"3","key":"7140_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1182\/blood.2019000633","volume":"134","author":"AJM Ferreri","year":"2019","unstructured":"Ferreri AJM, Calimeri T, Conte GM, et al. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-\u03b1 in primary CNS lymphoma. Blood. 2019;134(3):252\u201362.","journal-title":"Blood"},{"issue":"4","key":"7140_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226\u201335.","journal-title":"Nat Rev Urol"},{"issue":"12","key":"7140_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091\u2013103.","journal-title":"N Engl J Med"},{"issue":"5","key":"7140_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s43018-023-00539-6","volume":"4","author":"MK Bakht","year":"2023","unstructured":"Bakht MK, Yamada Y, Ku SY, et al. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nat Cancer. 2023;4(5):699\u2013715.","journal-title":"Nat Cancer"},{"issue":"12","key":"7140_CR37","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00259-018-4079-z","volume":"45","author":"A Afshar-Oromieh","year":"2018","unstructured":"Afshar-Oromieh A, Debus N, Uhrig M, et al. Impact of long-term androgen deprivation therapy on PSMA ligand PET\/CT in patients with castration-sensitive prostate cancer. Eur J Nucl Med Mol Imaging. 2018;45(12):2045\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7140_CR38","doi-asserted-by":"crossref","unstructured":"Bakht MK, Hayward JJ, Shahbazi-Raz F, et al. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells. Proc Natl Acad Sci U S A. 2022;119(4).","DOI":"10.1073\/pnas.2025710119"},{"issue":"9","key":"7140_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2967\/jnumed.121.263221","volume":"63","author":"JA Korsen","year":"2022","unstructured":"Korsen JA, Kalidindi TM, Khitrov S, et al. Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3. J Nucl Med. 2022;63(9):1401\u20137.","journal-title":"J Nucl Med"},{"issue":"2","key":"7140_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/ERC-18-0226","volume":"26","author":"MK Bakht","year":"2018","unstructured":"Bakht MK, Derecichei I, Li Y, et al. Neuroendocrine differentiation of prostate cancer leads to PSMA suppression. Endocr Relat Cancer. 2018;26(2):131\u201346.","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"7140_CR41","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/RLU.0000000000004230","volume":"47","author":"S Qiu","year":"2022","unstructured":"Qiu S, Dong A, Zhu Y, Zuo C. 68 Ga-PSMA-11 and 18 F-FDG PET\/CT in a Case of Ductal Adenocarcinoma of the Prostate. Clin Nucl Med. 2022;47(9):836\u20138.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"7140_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/RLU.0000000000004742","volume":"48","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Dong A, Bai Y, Zuo C. Prostate-specific membrane antigen uptake heterogeneity in mixed ductal-acinar adenocarcinoma of the prostate. Clin Nucl Med. 2023;48(8):750\u20132.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"7140_CR43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41391-023-00759-y","volume":"27","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou L, Qi L, et al. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate Cancer Prostatic Dis. 2023;27(4):720\u20137.","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"11","key":"7140_CR44","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1007\/s00259-023-06277-2","volume":"50","author":"D Dai","year":"2023","unstructured":"Dai D, Yu J, Huang T, et al. PET imaging of new target CDK19 in prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(11):3452\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"7140_CR45","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1021\/acs.jmedchem.3c01135","volume":"66","author":"Q Gan","year":"2023","unstructured":"Gan Q, Cui K, Cao Q, Zhang N, Yang MF, Yang X. Development of a (18)F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer. J Med Chem. 2023;66(21):14623\u201332.","journal-title":"J Med Chem"},{"issue":"3","key":"7140_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ccell.2019.02.005","volume":"35","author":"A Sinha","year":"2019","unstructured":"Sinha A, Huang V, Livingstone J, et al. The Proteogenomic Landscape of Curable Prostate Cancer. Cancer Cell. 2019;35(3):414-427.e416.","journal-title":"Cancer Cell"},{"issue":"16","key":"7140_CR47","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.3390\/ijms241612675","volume":"24","author":"G Trencs\u00e9nyi","year":"2023","unstructured":"Trencs\u00e9nyi G, Enyedi KN, Mez\u0151 G, Halmos G, K\u00e9pes Z. NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review. Int J Mol Sci. 2023;24(16):12675.","journal-title":"Int J Mol Sci."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07140-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07140-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07140-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T07:02:58Z","timestamp":1749711778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07140-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7140"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07140-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Xiangya Hospital (No. 202110113, No. 202310909). The study adheres to the principles of the Helsinki Declaration and is meticulously executed according to established protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No potential conflicts of interest relevant to this article exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}